Want to join the conversation?
R&D expense for 3Q15 was $174.8MM, up $16.6MM YoverY. R&D increased primarily due to the impact of the acquired EPD business, which raised R&D by approx. $17MM in the current quarter. Additionally, R&D increased due to the continued development of $MYL respiratory, insulin and biologics programs, partially offset by lower expense on other programs.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!